Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Kraig Biocraft Laboratories (KBLB) Cash from Operations (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Cash from Operations for 11 consecutive years, with 441594.0 as the latest value for Q4 2022.

  • Quarterly Cash from Operations fell 11.75% to 441594.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 1887187.0 through Dec 2022, down 4.8% year-over-year, with the annual reading at 1788970.0 for FY2025, 2.73% up from the prior year.
  • Cash from Operations hit 441594.0 in Q4 2022 for Kraig Biocraft Laboratories, up from 485456.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 28207.0 in Q3 2018 to a low of 548152.0 in Q2 2021.
  • Historically, Cash from Operations has averaged 319080.54 across 4 years, with a median of 418653.0 in 2021.
  • Biggest five-year swings in Cash from Operations: surged 81.11% in 2018 and later plummeted 187.15% in 2019.
  • Year by year, Cash from Operations stood at 65642.0 in 2018, then crashed by 242.84% to 225046.0 in 2019, then tumbled by 75.59% to 395150.0 in 2021, then decreased by 11.75% to 441594.0 in 2022.
  • Business Quant data shows Cash from Operations for KBLB at 441594.0 in Q4 2022, 485456.0 in Q3 2022, and 480818.0 in Q2 2022.